Prediction of Local Recurrence Using Clinical and Radiomic Features in Lung Oligometastases Treated with Stereotactic Body Radiotherapy
Technology in Cancer Research & Treatment · 2025
DOI: 10.1177/15330338251400229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Rahmi Atıl Aksoy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Akdeniz University School of Medicine, Antalya, Turkey. Hauptthemen laut MEDLINE: Radiosurgery, Lung Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
This study aimed to develop machine learning-based models to predict local recurrence in patients with lung oligometastases receiving stereotactic body radiotherapy (SBRT), using both clinical and radiomic features.
Methods
A total of 80 lung oligometastases from 65 patients treated with SBRT were retrospectively evaluated. Clinical variables and radiomic features extracted from non-contrast planning computed tomography (CT) scans were collected. The dataset was randomly divided into training (70%) and test (30%) sets. Multivariable Cox proportional hazards models were developed to predict local recurrence using three feature sets: clinical only, radiomic only, and combined. Predictive performance was assessed using the concordance index (C-index).
Results
The median follow-up duration was 11.8 months (range, 6.0-31.5), during which local recurrence was observed in 12 out of 80 lesions (15.0%) treated with SBRT. Multivariable Cox proportional hazards models for predicting local recurrence achieved C-index of 0.75 for the clinical model, 0.74 for the radiomic model, and 0.78 for the combined model. The combined model incorporated three features: soft tissue sarcoma histology (HR 7.70, 95% CI 1.65-35.87, p = 0.009), metastasis size (HR 1.07, 95% CI 1.01-1.14, p = 0.036), and Rad-score (HR 4.05, 95% CI 1.58-10.36, p = 0.003).
Conclusion
These findings highlight the potential of machine learning-based models that integrate clinical and radiomic features to predict local recurrence in patients with lung oligometastases undergoing SBRT. Further validation in large, multicenter, and independent cohorts is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Akdeniz University School of Medicine, Antalya, Turkey.
- Department of Radiation Oncology, Izmir City Hospital, Izmir, Turkey.
- Department of Computer Engineering, Akdeniz University Faculty of Engineering, Antalya, Turkey.
- Department of Pulmonology, Akdeniz University School of Medicine, Antalya, Turkey.
ORCID-Profile: Rahmi Atıl Aksoy, Timur Koca, Taner Danisman
Zitieren
APA
Aksoy, R. A., Koca, T., Danisman, T., Dirol, H., & Korcum, A. F. (2025). Prediction of Local Recurrence Using Clinical and Radiomic Features in Lung Oligometastases Treated with Stereotactic Body Radiotherapy. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251400229
Vancouver
Aksoy RA, Koca T, Danisman T, Dirol H, Korcum AF. Prediction of Local Recurrence Using Clinical and Radiomic Features in Lung Oligometastases Treated with Stereotactic Body Radiotherapy. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251400229
BibTeX
@article{Aksoy2025,
author = {Aksoy, Rahmi Atıl and Koca, Timur and Danisman, Taner and Dirol, Hulya and Korcum, Aylin Fidan},
title = {Prediction of Local Recurrence Using Clinical and Radiomic Features in Lung Oligometastases Treated with Stereotactic Body Radiotherapy},
journal = {Technology in Cancer Research & Treatment},
year = {2025},
doi = {10.1177/15330338251400229}
}
EUVIMED